Search research articles
Contact Us
Filters
Showing results (61-70 of 232) with videos related to
Page
of 24
Sort By:
Gynecologic Oncology
|
September 11, 2009
A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184
Helen J Mackay, Anna Tinker, Eric Winquist, et al.
Pediatric Blood & Cancer
|
July 5, 2007
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study
Anne-Marie Langevin, Mark Bernstein, John G Kuhn, et al.
Journal of the National Cancer Institute
|
September 1, 2022
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials
Andrea M Denicoff, S Percy Ivy, Tami T Tamashiro, et al.
Gynecologic Oncology
|
January 15, 2008
Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study
Howard Hochster, Thomas T Chen, Janice M Lu, et al.
The Oncologist
|
August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute
Arjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2015
Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program-Sponsored Single-Agent Phase I Studies
Jan H Beumer, Fei Ding, Hussein Tawbi, et al.
Leukemia & Lymphoma
|
October 13, 2011
Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma
Yasuhiro Oki, Amanda Copeland, Jorge Romaguera, et al.
Journal of Pediatric Hematology/Oncology
|
June 20, 2014
Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors
Catherine G Lam, Wayne L Furman, Chong Wang, et al.
Investigational New Drugs
|
September 14, 2006
Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules
Harold J Burstein, Beth Overmoyer, Rebecca Gelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trials
Philip A Philip, Kari Chansky, Michael LeBlanc, et al.
Page
of 24
Search research articles
Search
Showing results (61-70 of 232) with videos related to
Sort By:
Page
of 24
Gynecologic Oncology
|
September 11, 2009
A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184
Helen J Mackay, Anna Tinker, Eric Winquist, et al.
Pediatric Blood & Cancer
|
July 5, 2007
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study
Anne-Marie Langevin, Mark Bernstein, John G Kuhn, et al.
Journal of the National Cancer Institute
|
September 1, 2022
Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials
Andrea M Denicoff, S Percy Ivy, Tami T Tamashiro, et al.
Gynecologic Oncology
|
January 15, 2008
Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study
Howard Hochster, Thomas T Chen, Janice M Lu, et al.
The Oncologist
|
August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute
Arjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2015
Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program-Sponsored Single-Agent Phase I Studies
Jan H Beumer, Fei Ding, Hussein Tawbi, et al.
Leukemia & Lymphoma
|
October 13, 2011
Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma
Yasuhiro Oki, Amanda Copeland, Jorge Romaguera, et al.
Journal of Pediatric Hematology/Oncology
|
June 20, 2014
Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors
Catherine G Lam, Wayne L Furman, Chong Wang, et al.
Investigational New Drugs
|
September 14, 2006
Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules
Harold J Burstein, Beth Overmoyer, Rebecca Gelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trials
Philip A Philip, Kari Chansky, Michael LeBlanc, et al.
Page
of 24